Andrew Brenner
Professor of Medicine · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Credentials: · · · ·
History
UT M. D. Anderson Cancer Center Science Park
- 2003–2006
Texas A&M University Health Science Center at Scott and White Memorial Hosp
Research
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
British Journal of Cancer · 2020 · 796 citations
Investigational New Drugs · 2017 · 719 citations
Journal of Translational Medicine · 2018 · 425 citations
- RV
20 papers · 1 as a fellow
10 papers
8 papers
- PW
7 papers
7 papers
- YC
7 papers · 1 as a resident
6 papers
5 papers
Grants
- 1997–2031
Mays Cancer Center at UT San Antonio Health Science Center
National Cancer Institute · P30
Project lead · $331.5K · University of Texas Hlth Science Center
- 2023–2027
Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma
National Cancer Institute · R01
PI · $2.1M · University of Texas Hlth Science Center
- 2019–2026
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
National Cancer Institute · R01
Contact PI · $3M · University of Texas Hlth Science Center
- 2014–2020
Phase 2 Study of TH-302 for the Treatment of Glioblastoma
Food and Drug Administration · R01
Contact PI · $1.8M · University of Texas Hlth Science Center
Clinical trials
- 2026–2031
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Principal investigator · Recruiting · Phase 2
The University of Texas Health Science Center at San Antonio
- 2024–2028
Principal investigator · Recruiting · Phase 1
Cerenome
- 2021–2026
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Principal investigator · Active not recruiting · Phase 1
Cerenome
- 2021–2028
Principal investigator · Active not recruiting · Phase 2
SWOG Cancer Research Network